Haleon consumer healthcare brands

Haleon is a leading global consumer healthcare company that operates as an independent, publicly traded entity. Formed in July 2022, it was created through the strategic demerger and spin-off of the consumer healthcare division of GlaxoSmithKline (GSK) and its joint venture with Pfizer. Headquartered in Weybridge, England, Haleon carries a prestigious lineage that traces back to a London apothecary shop founded in 1715.

As of 2026, Haleon is a fully independent company listed on the London and New York Stock Exchanges. While originally formed with significant stakes held by GSK and Pfizer, both pharmaceutical giants have fully exited their positions, leaving the company's ownership primarily in the hands of global institutional investors like BlackRock. Haleon manages a vast portfolio of world-renowned 'power brands' including Sensodyne, Advil, Centrum, Panadol, and Voltaren.

The company utilizes a global manufacturing network to serve over 170 markets. While it has historically maintained several sites in the UK, it has moved to optimize production by shifting facilities to regions such as Slovakia (a major hub for oral care) and maintaining diverse manufacturing capabilities in North America, Europe, and Asia to ensure supply chain resilience for its essential health products.